{"version":"1.0","provider_name":"Zhejiang Hengkang Pharmaceutical","provider_url":"https:\/\/en.hengkangpharm.cn","author_name":"HengkangPharm","author_url":"https:\/\/en.hengkangpharm.cn\/index.php\/author\/admin\/","title":"Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate - Zhejiang Hengkang Pharmaceutical","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ZKXo5PYrXd\"><a href=\"https:\/\/en.hengkangpharm.cn\/index.php\/intermediates\/apixabanintermediate_503614-91-3\/\">Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/en.hengkangpharm.cn\/index.php\/intermediates\/apixabanintermediate_503614-91-3\/embed\/#?secret=ZKXo5PYrXd\" width=\"600\" height=\"338\" title=\"&#8220;Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate&#8221; &#8212; Zhejiang Hengkang Pharmaceutical\" data-secret=\"ZKXo5PYrXd\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/en.hengkangpharm.cn\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate is an intermediate for the preparation of apixaban, which is an antithrombotic drug. It is a direct inhibitor of factor Xa jointly developed by Bristol Myers Squibb and Pfizer in the United States. It was approved for market in the European Union in March 2011 and was approved for market by the FDA in the United States in December 2012.","thumbnail_url":"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/02\/image-41.png","thumbnail_width":230,"thumbnail_height":175}